Revelation Biosciences's total assets for Q3 2024 were $6.74M, a decrease of -45.07% from the previous quarter. REVB total liabilities were $4.07M for the fiscal quarter, a -63.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.